Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Mol Cell ; 59(4): 664-76, 2015 Aug 20.
Article in English | MEDLINE | ID: mdl-26236014

ABSTRACT

The most critical stage in initiation of melanoma metastasis is the radial to vertical growth transition, yet the triggers of this transition remain elusive. We suggest that the microenvironment drives melanoma metastasis independently of mutation acquisition. Here we examined the changes in microenvironment that occur during melanoma radial growth. We show that direct contact of melanoma cells with the remote epidermal layer triggers vertical invasion via Notch signaling activation, the latter serving to inhibit MITF function. Briefly, within the native Notch ligand-free microenvironment, MITF, the melanocyte lineage master regulator, binds and represses miR-222/221 promoter in an RBPJK-dependent manner. However, when radial growth brings melanoma cells into contact with distal differentiated keratinocytes that express Notch ligands, the activated Notch intracellular domain impairs MITF binding to miR-222/221 promoter. This de-repression of miR-222/221 expression triggers initiation of invasion. Our findings may direct melanoma prevention opportunities via targeting specific microenvironments.


Subject(s)
Keratinocytes/physiology , Melanoma, Experimental/secondary , Microphthalmia-Associated Transcription Factor/metabolism , Skin Neoplasms/pathology , Animals , Base Sequence , Binding Sites , Cell Communication , Cell Line, Tumor , Coculture Techniques , Gene Expression Regulation, Neoplastic , Melanoma, Experimental/metabolism , Mice, Inbred NOD , Mice, SCID , MicroRNAs/genetics , MicroRNAs/metabolism , Neoplasm Invasiveness , Neoplasm Transplantation , Promoter Regions, Genetic , RNA Interference , Receptors, Notch/metabolism , Signal Transduction , Skin Neoplasms/metabolism
2.
Wound Repair Regen ; 29(4): 637-641, 2021 07.
Article in English | MEDLINE | ID: mdl-33961308

ABSTRACT

Myofibroblasts, renowned for their contractility and extracellular matrix production, are widely considered the key effector cells for nearly all scars resulting from tissue repair processes, ranging from normal scars to extreme fibrosis. For example, it is often assumed that myofibroblasts underpin the characteristics of keloid scars, which are debilitating pathological skin scars lacking effective treatments because of a poor understanding of the disease mechanisms. Here, we present primary and published transcriptional and histological evidence that myofibroblasts are not consistently present in primary keloid lesions, and when alpha-smooth muscle actin (αSMA)-positive cells are detected, they are not greater in number or expressing more αSMA than in normal or hypertrophic scars. In conclusion, keloid scars do not appear to require αSMA-positive myofibroblasts; continuing to consider keloids on a quantitative spectrum with normal or hypertrophic scars, with αSMA serving as a biomarker of disease severity, is hindering advancement of understanding and therapy development.


Subject(s)
Cicatrix, Hypertrophic , Keloid , Biomarkers , Cicatrix, Hypertrophic/pathology , Humans , Keloid/pathology , Myofibroblasts/pathology , Wound Healing
3.
Genome Res ; 26(5): 601-11, 2016 05.
Article in English | MEDLINE | ID: mdl-26907635

ABSTRACT

During development, enhancers play pivotal roles in regulating gene expression programs; however, their involvement in cancer progression has not been fully characterized. We performed an integrative analysis of DNA methylation, RNA-seq, and small RNA-seq profiles from thousands of patients, including 25 diverse primary malignances and seven body sites of metastatic melanoma. We found that enhancers are consistently the most differentially methylated regions (DMR) as cancer progresses from normal to primary tumors and then to metastases, compared to other genomic features. Remarkably, identification of enhancer DMRs (eDMRs) enabled classification of primary tumors according to physiological organ systems, and in metastasis eDMRs are the most correlated with patient outcome. To further understand the eDMR role in cancer progression, we developed a model to predict genes and microRNAs that are regulated by enhancer and not promotor methylation, which shows high accuracy with chromatin architecture methods and was experimentally validated. Interestingly, among all metastatic melanoma eDMRs, the most correlated with patient survival were eDMRs that "switched" their methylation patterns back and forth between normal, primary, and metastases and target cancer drivers, e.g., KIT We further demonstrated that eDMR target genes were modulated in melanoma by the bone metastasis microenvironment, suggesting that eDMRs respond to microenvironmental cues in metastatic niches. Our findings that aberrant methylation in cancer cells mostly affects enhancers, which contribute to tumor progression and cancer cell plasticity, will facilitate development of epigenetic anticancer approaches.


Subject(s)
DNA Methylation , DNA, Neoplasm , Enhancer Elements, Genetic , Melanoma , Cell Line, Tumor , DNA, Neoplasm/genetics , DNA, Neoplasm/metabolism , Female , Humans , Male , Melanoma/genetics , Melanoma/metabolism , Melanoma/mortality
5.
Ann Vasc Surg ; 32: 130.e5-7, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26802291

ABSTRACT

A 63-year-old Caucasian taxi driver presented with a 3-week history of malaise, night sweats, 7 kg weight loss, generalized arthralgia, and persistent mid-lower abdominal pain. Blood inflammatory markers were raised, and a computed tomography scan demonstrated an irregular degeneration of the infrarenal aorta, with a differential diagnosis including aortic infection. An urgent type IV thoracoabdominal aneurysm repair was performed with a rifampicin-soaked aortic tube graft during an open procedure. No organisms were grown from multiple peripheral blood cultures or culture of the affected aorta. However, subsequent 16S ribosomal polymerase chain reaction analysis of the resected aorta identified Capnocytophaga canimorsus as the causative organism-a commensal that lives in the mouth of dogs and cats. The patient subsequently gave a history of multiple bites from his pet dog over recent months-the likely source of infection. He was treated with 8 weeks of intravenous antibiotics before switching to oral antibiotics for an additional 6 weeks.


Subject(s)
Aneurysm, Infected/microbiology , Aortic Aneurysm, Thoracic/microbiology , Bites and Stings/microbiology , Capnocytophaga/isolation & purification , Gram-Negative Bacterial Infections/microbiology , Aneurysm, Infected/diagnostic imaging , Aneurysm, Infected/surgery , Animals , Anti-Bacterial Agents/therapeutic use , Aortic Aneurysm, Thoracic/diagnostic imaging , Aortic Aneurysm, Thoracic/surgery , Aortography/methods , Bites and Stings/complications , Blood Vessel Prosthesis Implantation , Capnocytophaga/classification , Capnocytophaga/genetics , Computed Tomography Angiography , Dogs , Gram-Negative Bacterial Infections/diagnosis , Gram-Negative Bacterial Infections/transmission , Humans , Male , Middle Aged , Positron Emission Tomography Computed Tomography , Ribotyping , Treatment Outcome
6.
PLoS Genet ; 9(3): e1003357, 2013.
Article in English | MEDLINE | ID: mdl-23516376

ABSTRACT

During development, tissue-specific transcription factors regulate both protein-coding and non-coding genes to control differentiation. Recent studies have established a dual role for the transcription factor Pax6 as both an activator and repressor of gene expression in the eye, central nervous system, and pancreas. However, the molecular mechanism underlying the inhibitory activity of Pax6 is not fully understood. Here, we reveal that Trpm3 and the intronic microRNA gene miR-204 are co-regulated by Pax6 during eye development. miR-204 is probably the best known microRNA to function as a negative modulator of gene expression during eye development in vertebrates. Analysis of genes altered in mouse Pax6 mutants during lens development revealed significant over-representation of miR-204 targets among the genes up-regulated in the Pax6 mutant lens. A number of new targets of miR-204 were revealed, among them Sox11, a member of the SoxC family of pro-neuronal transcription factors, and an important regulator of eye development. Expression of Trpm/miR-204 and a few of its targets are also Pax6-dependent in medaka fish eyes. Collectively, this study identifies a novel evolutionarily conserved mechanism by which Pax6 controls the down-regulation of multiple genes through direct up-regulation of miR-204.


Subject(s)
Evolution, Molecular , Eye Proteins , Eye , Homeodomain Proteins , MicroRNAs , Paired Box Transcription Factors , Repressor Proteins , Animals , Binding Sites , Cell Differentiation/genetics , Crystallins/genetics , Crystallins/metabolism , Eye/growth & development , Eye/metabolism , Eye Proteins/genetics , Eye Proteins/metabolism , Gene Expression Regulation , Gene Expression Regulation, Developmental , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Mice , MicroRNAs/genetics , MicroRNAs/metabolism , PAX6 Transcription Factor , Paired Box Transcription Factors/genetics , Paired Box Transcription Factors/metabolism , Repressor Proteins/genetics , Repressor Proteins/metabolism , SOXC Transcription Factors/metabolism , TRPM Cation Channels/genetics , TRPM Cation Channels/metabolism , Vertebrates/genetics , Vertebrates/metabolism
7.
J Clin Microbiol ; 51(8): 2797-9, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23761143

ABSTRACT

Mycotic aneurysms, especially outside the aorta, are uncommon, with group A Streptococcus a particularly rare cause. We report a case of extra-aortic mycotic aneurysm following a sore throat without demonstrable bacteremia where identification of the pathological organism was made by molecular diagnostic techniques after a standard laboratory culture was negative.


Subject(s)
Aneurysm, Infected/diagnosis , Aneurysm, Infected/microbiology , Pharyngitis/complications , Streptococcal Infections/diagnosis , Streptococcal Infections/microbiology , Streptococcus pyogenes/isolation & purification , Aneurysm, Infected/pathology , Bacteriological Techniques , Humans , Male , Middle Aged , Molecular Diagnostic Techniques , Radiography, Abdominal , Streptococcal Infections/pathology , Tomography, X-Ray
8.
Matrix Biol ; 123: 1-16, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37660739

ABSTRACT

Fibrosis is associated with dramatic changes in extracellular matrix (ECM) architecture of unknown etiology. Here we exploit keloid scars as a paradigm to understand fibrotic ECM organization. We reveal that keloid patient fibroblasts uniquely produce a globally aligned ECM network in 2-D culture as observed in scar tissue. ECM anisotropy develops after rapid initiation of a fibroblast supracellular actin network, suggesting that cell alignment initiates ECM patterning. Keloid fibroblasts produce elevated levels of IL-6, and autocrine IL-6 production is both necessary and sufficient to induce cell and ECM alignment, as evidenced by ligand stimulation of normal dermal fibroblasts and treatment of keloid fibroblasts with the function blocking IL-6 receptor monoclonal antibody, tocilizumab. Downstream of IL-6, supracellular organization of keloid fibroblasts is controlled by activation of cell-cell adhesion. Adhesion formation inhibits contact-induced cellular overlap leading to nematic organization of cells and an alignment of focal adhesions. Keloid fibroblasts placed on isotropic ECM align the pre-existing matrix, suggesting that focal adhesion alignment leads to active anisotropic remodeling. These results show that IL-6-induced fibroblast cooperativity can control the development of a nematic ECM, highlighting both IL-6 signaling and cell-cell adhesions as potential therapeutic targets to inhibit this common feature of fibrosis.


Subject(s)
Keloid , Humans , Keloid/drug therapy , Interleukin-6/genetics , Interleukin-6/metabolism , Anisotropy , Cells, Cultured , Extracellular Matrix/metabolism , Fibroblasts/metabolism
9.
J Vasc Surg ; 55(4): 1138-40, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22178438

ABSTRACT

Despite advances in imaging techniques, mediastinoscopy remains an important tool for the staging of the mediastinum in non-small cell lung cancer and diagnosing lymphoma with mediastinal adenopathy. Injury to the arterial system during mediastinoscopy is infrequent but a potentially fatal complication. We report three cases of injury to the aorta and supra-aortic arteries sustained during mediastinoscopy. These were effectively managed by endovascular techniques. Patient recovery was uncomplicated and median length of stay was 3 days. This technique avoids major open surgery in a high-risk group of patients and may offer a mortality benefit and more rapid resumption of oncological treatment.


Subject(s)
Aneurysm, False/therapy , Angioplasty/methods , Aorta, Thoracic/injuries , Mediastinal Neoplasms/diagnosis , Mediastinoscopy/adverse effects , Adult , Aged , Aneurysm, False/etiology , Aorta, Thoracic/diagnostic imaging , Female , Follow-Up Studies , Hodgkin Disease/diagnosis , Hodgkin Disease/surgery , Humans , Lung Neoplasms/diagnosis , Lung Neoplasms/surgery , Male , Mediastinal Neoplasms/surgery , Mediastinoscopy/methods , Multivariate Analysis , Risk Assessment , Sampling Studies , Stents , Tomography, X-Ray Computed/methods , Treatment Outcome
10.
J Endovasc Ther ; 19(1): 79-85, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22313206

ABSTRACT

PURPOSE: To assess whether deployment of an endograft limb in the external iliac artery (EIA) increases the rate of limb occlusion following endovascular aneurysm repair (EVAR). METHODS: Interrogation of a prospectively maintained database identified 661 patients (596 men; median age 73 years, range 37-93) with infrarenal abdominal aortic aneurysm who underwent EVAR between 1996 and 2010 using Zenith stent-grafts predominately. Of these, 567 patients [56 (9.9%) women] had both endograft limbs deployed in the CIA (1203 limbs at risk), while 94 patients [9 (9.6%) women] had at least 1 limb in the EIA (22 bilateral; 116 limbs at risk). An adjunctive bare metal stent was used in 8 (9%) limbs deployed in the EIA. RESULTS: There were 31 limb occlusions, all unilateral: 17 (3%) patients in the CIA group had an occluded limb (1% of limbs at risk) vs. 14 (15%) patients in the EIA group (12% of limbs at risk; p<0.0001). The median time to occlusion was 3 months (0-60) in the CIA group and 1 month (0-36) in the EIA group. The majority of occlusions were treated by extra-anatomical revascularization, most often a femorofemoral crossover bypass. No legs were amputated following occlusion of a limb placed in the CIA, but there were 3 amputations in the EIA group (p=0.003). CONCLUSION: Deployment of endograft limbs into the EIA led to a higher rate of occlusion and leg amputation. Increased tortuosity of the EIA and a smaller caliber vessel are likely to account for the increased risk.


Subject(s)
Aortic Aneurysm, Abdominal/surgery , Blood Vessel Prosthesis Implantation/adverse effects , Endovascular Procedures/adverse effects , Graft Occlusion, Vascular/etiology , Iliac Artery/surgery , Adult , Aged , Aged, 80 and over , Amputation, Surgical , Angiography, Digital Subtraction , Aortic Aneurysm, Abdominal/diagnostic imaging , Aortic Aneurysm, Abdominal/physiopathology , Blood Vessel Prosthesis , Blood Vessel Prosthesis Implantation/instrumentation , Endovascular Procedures/instrumentation , Female , Graft Occlusion, Vascular/physiopathology , Graft Occlusion, Vascular/surgery , Humans , Iliac Artery/diagnostic imaging , Iliac Artery/physiopathology , Kaplan-Meier Estimate , London , Male , Middle Aged , Prosthesis Design , Reoperation , Risk Assessment , Risk Factors , Stents , Time Factors , Treatment Outcome , Vascular Patency
11.
Cancer Res ; 82(22): 4164-4178, 2022 11 15.
Article in English | MEDLINE | ID: mdl-36084256

ABSTRACT

Exercise prevents cancer incidence and recurrence, yet the underlying mechanism behind this relationship remains mostly unknown. Here we report that exercise induces the metabolic reprogramming of internal organs that increases nutrient demand and protects against metastatic colonization by limiting nutrient availability to the tumor, generating an exercise-induced metabolic shield. Proteomic and ex vivo metabolic capacity analyses of murine internal organs revealed that exercise induces catabolic processes, glucose uptake, mitochondrial activity, and GLUT expression. Proteomic analysis of routinely active human subject plasma demonstrated increased carbohydrate utilization following exercise. Epidemiologic data from a 20-year prospective study of a large human cohort of initially cancer-free participants revealed that exercise prior to cancer initiation had a modest impact on cancer incidence in low metastatic stages but significantly reduced the likelihood of highly metastatic cancer. In three models of melanoma in mice, exercise prior to cancer injection significantly protected against metastases in distant organs. The protective effects of exercise were dependent on mTOR activity, and inhibition of the mTOR pathway with rapamycin treatment ex vivo reversed the exercise-induced metabolic shield. Under limited glucose conditions, active stroma consumed significantly more glucose at the expense of the tumor. Collectively, these data suggest a clash between the metabolic plasticity of cancer and exercise-induced metabolic reprogramming of the stroma, raising an opportunity to block metastasis by challenging the metabolic needs of the tumor. SIGNIFICANCE: Exercise protects against cancer progression and metastasis by inducing a high nutrient demand in internal organs, indicating that reducing nutrient availability to tumor cells represents a potential strategy to prevent metastasis. See related commentary by Zerhouni and Piskounova, p. 4124.


Subject(s)
Exercise , Melanoma , Nutrients , Proteomics , Animals , Humans , Mice , Glucose/metabolism , Melanoma/genetics , Melanoma/metabolism , Melanoma/pathology , Prospective Studies , TOR Serine-Threonine Kinases/genetics , TOR Serine-Threonine Kinases/metabolism , Exercise/physiology , Nutrients/genetics , Nutrients/metabolism
12.
J Vasc Surg ; 54(6): 1580-7, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21944907

ABSTRACT

BACKGROUND: The term acute aortic syndrome (AAS) encompasses a range of conditions that have a risk of imminent aortic rupture and where delays in treatment result in increased mortality. Endovascular treatment offers an attractive alternative to open surgery but little is known about the durability of the repair and the factors that predict mortality. METHODS: Prospective data were collected for a cohort of 110 consecutive patients with endovascular treatment for AAS. Patient and procedural characteristics were related to short- and midterm outcome using multivariate logistic regression analysis. RESULTS: There were 75 men and 35 women with a median age of 68 (range 57-76) years. The pathologies treated were acute dissection (35), symptomatic aneurysm (32), infected aneurysm (18), transection (12), chronic dissection (9), penetrating ulcer (3), and intramural hematoma (1). Thirty-day mortality was 12.7% and this was associated with hypotension (odds ratio [OR], 5.25), use of general anesthetic (OR, 5.23), long procedure duration (OR, 2.03), and increasing age (OR, 1.07). The causes of death were aortic rupture (4), myocardial infarction (4), stroke (3), and multisystem organ failure (3). The stroke and paraplegia rates were 7.3% and 6.4%, respectively. The 1-year survival was 81% and the 5-year survival 63%. Secondary procedures were required in 13 (11.8%) patients. Factors associated with death at 1 year were presence of an aortic fistula (OR, 9.78), perioperative stroke (OR, 5.87), and use of general anesthetic (OR, 3.76); and at 5 years were aortic fistula (OR, 12.31) and increasing age (OR, 1.06). CONCLUSIONS: Acute aortic syndrome carries significant early and late mortality. Emergency endovascular repair offers a minimally invasive treatment option associated with acceptable short and midterm results. Continued surveillance is important as secondary procedures and aortic-related deaths continue to occur throughout the follow-up period.


Subject(s)
Aorta, Thoracic , Aortic Diseases/surgery , Endovascular Procedures , Aged , Aortic Diseases/complications , Aortic Diseases/mortality , Cohort Studies , Female , Humans , Logistic Models , Male , Middle Aged , Risk Factors , Survival Rate , Syndrome , Treatment Outcome
13.
J Invest Dermatol ; 141(12): 2944-2956.e6, 2021 12.
Article in English | MEDLINE | ID: mdl-34186058

ABSTRACT

Almost half of the human microRNAs (miRNAs) are encoded in clusters. Although transcribed as a single unit, the levels of individual mature miRNAs often differ. The mechanisms underlying differential biogenesis of clustered miRNAs and the resulting physiological implications are mostly unknown. In this study, we report that the melanoma master transcription regulator MITF regulates the differential expression of the 99a/let-7c/125b-2 cluster by altering the distribution of RNA polymerase II along the cluster. We discovered that MITF interacts with TRIM28, a known inhibitor of RNA polymerase II transcription elongation, at the mIR-let-7c region, resulting in the pausing of RNA polymerase II activity and causing an elevation in mIR-let-7c expression; low levels of RNA polymerase II occupation over miR-99a and miR-125b-2 regions decreases their biogenesis. Furthermore, we showed that this differential expression affects the phenotypic state of melanoma cells. RNA-sequencing analysis of proliferative melanoma cells that express miR-99a and miR-125b mimics revealed a transcriptomic shift toward an invasive phenotype. Conversely, expression of a mIR-let-7c mimic in invasive melanoma cells induced a shift to a more proliferative state. We confirmed direct target genes of these miRNAs, including FGFR3, BAP1, Bcl2, TGFBR1, and CDKN1A. Our study demonstrates an MITF-governed biogenesis mechanism that results in differential expression of clustered 99a/let-7c/125b-2 miRNAs that control melanoma progression.


Subject(s)
Adaptation, Physiological/physiology , Melanoma/genetics , MicroRNAs/genetics , Animals , Cell Line, Tumor , Female , HEK293 Cells , Humans , Melanoma/physiopathology , Mice , Microphthalmia-Associated Transcription Factor/physiology , Transcription, Genetic , Tripartite Motif-Containing Protein 28/physiology
16.
Nat Commun ; 10(1): 5657, 2019 12 11.
Article in English | MEDLINE | ID: mdl-31827083

ABSTRACT

MicroRNA (miRNA) biogenesis initiates co-transcriptionally, but how the Microprocessor machinery pinpoints the locations of short precursor miRNA sequences within long flanking regions of the transcript is not known. Here we show that miRNA biogenesis depends on DNA methylation. When the regions flanking the miRNA coding sequence are highly methylated, the miRNAs are more highly expressed, have greater sequence conservation, and are more likely to drive cancer-related phenotypes than miRNAs encoded by unmethylated loci. We show that the removal of DNA methylation from miRNA loci leads to their downregulation. Further, we found that MeCP2 binding to methylated miRNA loci halts RNA polymerase II elongation, leading to enhanced processing of the primary miRNA by Drosha. Taken together, our data reveal that DNA methylation directly affects miRNA biogenesis.


Subject(s)
MicroRNAs/genetics , Animals , Cell Line , DNA Methylation , Humans , Methyl-CpG-Binding Protein 2/genetics , Methyl-CpG-Binding Protein 2/metabolism , Mice , MicroRNAs/metabolism , Open Reading Frames , RNA Processing, Post-Transcriptional
17.
Matrix Biol Plus ; 4: 100016, 2019 Nov.
Article in English | MEDLINE | ID: mdl-33543013

ABSTRACT

Following wound damage to the skin, the scarring spectrum is wide-ranging, from a manageable normal scar through to pathological keloids. The question remains whether these fibrotic lesions represent simply a quantitative extreme, or alternatively, whether they are qualitatively distinct. A three-way comparison of the extracellular matrix (ECM) composition of normal skin, normal scar and keloids was performed using quantitative discovery-based proteomics. This approach identified 40 proteins that were significantly altered in keloids compared to normal scars, and strikingly, 23 keloid-unique proteins. The major alterations in keloids, when functionally grouped, showed many changes in proteins involved in ECM assembly and fibrillogenesis, but also a keloid-associated loss of proteases, and a unique cartilage-like composition, which was also evident histologically. The presence of Aggrecan and Collagen II in keloids suggest greater plasticity and mis-differentiation of the constituent cells. This study characterises the ECM of both scar types to a depth previously underappreciated. This thorough molecular description of keloid lesions relative to normal scars is an essential step towards our understanding of this debilitating clinical problem, and how best to treat it.

18.
J Exp Med ; 215(12): 3075-3093, 2018 12 03.
Article in English | MEDLINE | ID: mdl-30470719

ABSTRACT

Cancer-associated fibroblasts (CAFs) are highly prominent in breast tumors, but their functional heterogeneity and origin are still largely unresolved. We report that bone marrow (BM)-derived mesenchymal stromal cells (MSCs) are recruited to primary breast tumors and to lung metastases and differentiate to a distinct subpopulation of CAFs. We show that BM-derived CAFs are functionally important for tumor growth and enhance angiogenesis via up-regulation of Clusterin. Using newly generated transgenic mice and adoptive BM transplantations, we demonstrate that BM-derived fibroblasts are a substantial source of CAFs in the tumor microenvironment. Unlike resident CAFs, BM-derived CAFs do not express PDGFRα, and their recruitment resulted in a decrease in the percentage of PDGFRα-expressing CAFs. Strikingly, decrease in PDGFRα in breast cancer patients was associated with worse prognosis, suggesting that BM-derived CAFs may have deleterious effects on survival. Therefore, PDGFRα expression distinguishes two functionally unique CAF populations in breast tumors and metastases and may have important implications for patient stratification and precision therapeutics.


Subject(s)
Bone Marrow Cells/metabolism , Breast Neoplasms/metabolism , Mammary Neoplasms, Animal/metabolism , Mesenchymal Stem Cells/metabolism , Neoplasm Proteins/metabolism , Receptor, Platelet-Derived Growth Factor alpha/metabolism , Tumor Microenvironment , Animals , Bone Marrow Cells/pathology , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Female , Fibroblasts , Humans , Mammary Neoplasms, Animal/genetics , Mammary Neoplasms, Animal/pathology , Mesenchymal Stem Cells/pathology , Mice , Mice, Transgenic , Neoplasm Metastasis , Neoplasm Proteins/genetics , Receptor, Platelet-Derived Growth Factor alpha/genetics
19.
Nat Commun ; 8(1): 1022, 2017 10 18.
Article in English | MEDLINE | ID: mdl-29044103

ABSTRACT

Ectopic expression of lineage master regulators induces transdifferentiation. Whether cell fate transitions can be induced during various developmental stages has not been systemically examined. Here we discover that amongst different developmental stages, mouse embryonic stem cells (mESCs) are resistant to cell fate conversion induced by the melanocyte lineage master regulator MITF. By generating a transgenic system we exhibit that in mESCs, the pluripotency master regulator Oct4, counteracts pro-differentiation induced by Mitf by physical interference with MITF transcriptional activity. We further demonstrate that mESCs must be released from Oct4-maintained pluripotency prior to ectopically induced differentiation. Moreover, Oct4 induction in various differentiated cells represses their lineage identity in vivo. Alongside, chromatin architecture combined with ChIP-seq analysis suggest that Oct4 competes with various lineage master regulators for binding promoters and enhancers. Our analysis reveals pluripotency and transdifferentiation regulatory principles and could open new opportunities in the field of regenerative medicine.


Subject(s)
Cell Differentiation/genetics , Microphthalmia-Associated Transcription Factor/genetics , Mouse Embryonic Stem Cells/metabolism , Octamer Transcription Factor-3/genetics , Animals , Cell Line, Tumor , Cell Transdifferentiation/genetics , Cells, Cultured , Embryo, Mammalian/cytology , Fibroblasts/cytology , Fibroblasts/metabolism , Gene Expression Profiling , Gene Expression Regulation, Developmental , Humans , Mice , Mice, Transgenic , Microphthalmia-Associated Transcription Factor/metabolism , Mouse Embryonic Stem Cells/cytology , Octamer Transcription Factor-3/metabolism
20.
Pathogens ; 5(3)2016 Aug 03.
Article in English | MEDLINE | ID: mdl-27527221

ABSTRACT

The bronchial epithelium provides protection against pathogens from the inhaled environment through the formation of a highly-regulated barrier. In order to understand the pulmonary diseases melioidosis and tularemia caused by Burkholderia thailandensis and Fransicella tularensis, respectively, the barrier function of the human bronchial epithelium were analysed. Polarised 16HBE14o- or differentiated primary human bronchial epithelial cells (BECs) were exposed to increasing multiplicities of infection (MOI) of B. thailandensis or F. tularensis Live Vaccine Strain and barrier responses monitored over 24-72 h. Challenge of polarized BECs with either bacterial species caused an MOI- and time-dependent increase in ionic permeability, disruption of tight junctions, and bacterial passage from the apical to the basolateral compartment. B. thailandensis was found to be more invasive than F. tularensis. Both bacterial species induced an MOI-dependent increase in TNF-α release. An increase in ionic permeability and TNF-α release was induced by B. thailandensis in differentiated BECs. Pretreatment of polarised BECs with the corticosteroid fluticasone propionate reduced bacterial-dependent increases in ionic permeability, bacterial passage, and TNF-α release. TNF blocking antibody Enbrel(®) reduced bacterial passage only. BEC barrier properties are disrupted during respiratory bacterial infections and targeting with corticosteroids or anti-TNF compounds may represent a therapeutic option.

SELECTION OF CITATIONS
SEARCH DETAIL